tetano
Editor, Senior Moderator
Emerg Infect Dis. 2010 Jun;16(6):971-3.
Invasive Aspergillosis after Pandemic (H1N1) 2009.
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson Iii GR.
New York-Presbyterian Hospital, New York, New York, USA (A. Lat, N. Bhadelia, B. Miko, E. Yoko Furuya); and University of California, Davis, Sacramento, California, USA (G.R. Thompson III).
Abstract
We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects and impair ciliary clearance. These defects, combined with high-dose corticosteroids prescribed during influenza-associated adult respiratory distress syndrome, may be novel risk factors predisposing otherwise immunocompetent patients to invasive aspergillosis.
PMID: 20507748 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20507748
Invasive Aspergillosis after Pandemic (H1N1) 2009.
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson Iii GR.
New York-Presbyterian Hospital, New York, New York, USA (A. Lat, N. Bhadelia, B. Miko, E. Yoko Furuya); and University of California, Davis, Sacramento, California, USA (G.R. Thompson III).
Abstract
We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects and impair ciliary clearance. These defects, combined with high-dose corticosteroids prescribed during influenza-associated adult respiratory distress syndrome, may be novel risk factors predisposing otherwise immunocompetent patients to invasive aspergillosis.
PMID: 20507748 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20507748